EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY 4.0

Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m

Dominic Gilliand, Tsogyal D Latshang, Sayaka S Aeschbacher, Fabienne Huber, Deborah Flueck, Mona Lichtblau, Stefanie Ulrich, Elisabeth D Hasler, Philipp M Scheiwiller, Julian Müller, Silvia Ulrich, Konrad E Bloch and 1 more

Experimental Physiology · 2026

DOI: 10.1113/ep093003 ↗

At a glance

Randomisierte kontrollierte Studie in Experimental Physiology, 2026. Written by Dominic Gilliand and 12 co-authors. Institution: Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland. Major MEDLINE topics: Altitude, Pulmonary Disease, Chronic Obstructive, Cerebrovascular Circulation, Oxygen Inhalation Therapy. 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: Lunge Zürich, Swiss National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

We investigated whether nocturnal oxygen therapy improves next‐day cerebrovascular function in lowlanders with chronic obstructive pulmonary disease (COPD) staying at moderate altitude. This randomized, placebo‐controlled single‐blind crossover trial was performed in moderate‐to‐severe COPD patients [forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC)

Subjects

MeSH terms (MEDLINE)

AltitudePulmonary Disease, Chronic ObstructiveCerebrovascular CirculationOxygen Inhalation TherapyHumansCross-Over StudiesMaleFemaleMiddle AgedAgedSingle-Blind MethodOxygenOxygen SaturationOximetry

Author keywords

cerebrovascular reactivitychronic obstructive pulmonary diseasehypoxiatranscranial Doppler ultrasound

Substances

Oxygen

Authors and institutions

  • Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland.
  • Research Department, Swiss University of Traditional Chinese Medicine, Bad Zurzach, Switzerland.

ORCID profiles: Michael Furian

Funding

  • Lunge Zürich
  • Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Cite

APA

Gilliand, D., Latshang, T. D., Aeschbacher, S. S., Huber, F., Flueck, D., Lichtblau, M., Ulrich, S., Hasler, E. D., Scheiwiller, P. M., Müller, J., Ulrich, S., Bloch, K. E., & Furian, M. (2026). Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m. Experimental Physiology. https://doi.org/10.1113/ep093003

Vancouver

Gilliand D, Latshang TD, Aeschbacher SS, Huber F, Flueck D, Lichtblau M, et al. Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m. Experimental Physiology. 2026. doi:10.1113/ep093003

BibTeX
@article{Gilliand2026,
  author = {Gilliand, Dominic and Latshang, Tsogyal D and Aeschbacher, Sayaka S and Huber, Fabienne and Flueck, Deborah and Lichtblau, Mona and Ulrich, Stefanie and Hasler, Elisabeth D and Scheiwiller, Philipp M and Müller, Julian and Ulrich, Silvia and Bloch, Konrad E and Furian, Michael},
  title = {Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m},
  journal = {Experimental Physiology},
  year = {2026},
  doi = {10.1113/ep093003}
}
Start for free →